Hypercalcemia and acute kidney injury induced by eldecalcitol in patients with osteoporosis: a case series of 32 patients at a single facility

Background: Eldecalcitol (ELD) is an active vitamin D(3) analog that is widely used in Japan for the treatment of osteoporosis. The most common adverse drug reaction of ELD is hypercalcemia. However, few reports have focused on acute kidney injury (AKI) associated with ELD-induced hypercalcemia. Mat...

Descripción completa

Detalles Bibliográficos
Autores principales: Aihara, Seishi, Yamada, Shunsuke, Oka, Hideaki, Kamimura, Taro, Nakano, Toshiaki, Tsuruya, Kazuhiko, Harada, Atsumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442105/
https://www.ncbi.nlm.nih.gov/pubmed/30909788
http://dx.doi.org/10.1080/0886022X.2019.1578667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442105/
https://www.ncbi.nlm.nih.gov/pubmed/30909788
http://dx.doi.org/10.1080/0886022X.2019.1578667

Ejemplares similares